Navigation Links
STALLERGENES : Sales Guidance Exceeded : EUR193 Million, up 13%
Date:1/14/2010

preliminary results will take place in a few weeks.

The authorisation to carry out a Phase III clinical study on children for Actair(R) (immunotherapy tablet for dust mites) on 450 patients has been granted in Europe and patients are being recruited. The preliminary results should be published in mid-2011.

The presentation of the clinical results obtained in 2009 and at the start of 2010 will be the subject of a specific meeting, to be organised shortly.

About Stallergenes

Stallergenes is a European biopharmaceutical laboratory specialising in treatments by immunotherapy for the prevention and treatment of allergy-related respiratory conditions, such as rhino conjunctivitis, rhinitis and allergic asthma. Stallergenes is ranked seventh among French pharmaceutical laboratories. A pioneer and a leader in immunotherapy treatments by sublingual administration, Stallergenes dedicates 21% (gross) of its sales to its Research and Development activities, which are primarily directed at developing a new therapeutic range enabling the provision of immunotherapy treatments by sublingual tablets.

Stallergenes realised 2009 sales of EUR 193 million, with over 500,000 patients treated with Stallergenes desensitisation products.

    Euronext Paris (Compartment B).
    SBF 120 index.
    ISIN code: FR0000065674
    Reuters code: GEN.PA
    Bloomberg code: GEN.FP

For further financial information, please visit our website: http://www.stallergenes.com

SOURCE Stallergenes


'/>"/>
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe
2. STALLERGENES: Immunotherapy Tablet Containing Recombinant Allergen (rBet v 1) of Birch Pollen: Positive Results for a Phase IIb/III Trial
3. STALLERGENES: 1st Half-Year 2009: Performance Ahead of Expectations
4. STALLERGENES: Strong Sales Growth in 1st Half-Year: up 12% Full-Year Guidance Maintained
5. Stallergenes : Investor Meeting: Webcast is Available
6. STALLERGENES: 2008: Strong Performance
7. Stallergenes Signs an Exclusive Partnership Agreement With Solvay Pharmaceuticals for the Promotion and Distribution of its Products in Russia and the CIS*
8. Stallergenes: 2008: Sales Up 16% - Excellent Performance - Guidance Exceeded
9. Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
10. Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14%
11. Stallergenes Inaugurates the Biggest Pharmaceutical Allergen Production Unit in the World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... DALLAS , May 22, 2015 Baylor ... and the Translational Genomics Research Institute (TGen) in ... that will focus on accelerating early detection and treatments for ... science of both institutions will lead to new clinical trials ... therapies – bridging the gap from bench to bedside across ...
(Date:5/21/2015)... 2015  Prima Biomed Ltd. (NASDAQ: PBMD ) ... become a leader in the development of immunotherapeutic products ... final CVac data from the Phase II CAN-003 ovarian ... a clinically meaningful improvement in Overall Survival ("OS") over ... In the group of second remission patients (n=20), ...
(Date:5/21/2015)... Bridgewater, NJ (PRWEB) May 21, 2015 ... and a method for diagnostic or therapeutic imaging within ... the apparatus uses an endoscope having a low cost, ... original USPTO filing date was October 18, 2013 and ... The technology enables the physician to customize the ...
(Date:5/21/2015)... 21, 2015 Veolia’s environmental monitoring ... North American distribution agreement with VWR to distribute ... With more than 160 years of experience, VWR, ... for laboratory and production facilities, has cultivated a ... differentiated services to enable science. Endetec’s TECTA™ ...
Breaking Biology Technology:Precision Medicine Collaboration to Increase Options for Cancer Patients 2Precision Medicine Collaboration to Increase Options for Cancer Patients 3Precision Medicine Collaboration to Increase Options for Cancer Patients 4Correction Continues after Big Move - BrokerBank Securities, Inc. 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 3Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2
... Feb. 1, 2011 Techne Corporation,s (Nasdaq: TECH ... 2010 increased 7.3% to $26.5 million or $0.71 per diluted ... for the quarter ended December 31, 2009.  The increase in ... in sales and a decrease in income taxes due to ...
... 2011 MediVet-America today announced the opening of ... technical support for in-clinic animal stem cell procedures, ... Banking Services, Autologous Conditional Serum Processing, and Cell ... MediVet-America, the leading developer of stem cell ...
... , The more we learn about biology, the closer we ... more complicated our understanding of disease itself becomes. ... microbial ecologies in human intestines and the common but serious ... From past genomic studies, we have learned that a mind-boggling ...
Cached Biology Technology:Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011 2Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011 3Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011 4Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011 5Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011 6Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011 7MediVet-America, Leading Animal Stem Cell Developer, Launches MediVet Lab Services 2Specific populations of gut bacteria linked to fatty liver 2Specific populations of gut bacteria linked to fatty liver 3Specific populations of gut bacteria linked to fatty liver 4
(Date:4/20/2015)... The announcement comes as demand ... Management (GRM), Ireland,s foremost records management ... built up an impressive track record of clients within the ... the records management sector in Dubai . ... staffbase and employ a further eight staff members at its ...
(Date:4/13/2015)... YORK , April 13, 2015 ... by TechSci Research, "Global Biometrics Market Forecast & Opportunities, ... register a CAGR of around 14% till 2020. ... governments for large scale implementation and review of ... and launch of new products with greater efficiency, ...
(Date:4/8/2015)... N.C. , April 8, 2015  Infinisource, ... solutions and services, and Morpho, a leading supplier ... partnership to produce the market,s most advanced biometrically-enabled ... Infinisource,s iSolved NXG time clock is setting a ... and labor data for the small and mid-size ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3
... Researchers at the University of Michigan Comprehensive Cancer Center ... treat multiple types of cancer. A study, published this ... that AT-406 effectively targets proteins that block normal cell death ... while not harming normal cells. The researchers believe the drug ...
... 29, 2011)Uterine fibroid embolizationan interventional radiology treatment for ... in the muscular wall of the uterusimproves a ... are specifically caused by those fibroids, confirm researchers ... Scientific Meeting in Chicago, Ill. "Uterine fibroid ...
... formulation of antioxidants taken orally before imaging with ionizing ... of Interventional Radiology,s 36th Annual Scientific Meeting in Chicago, ... clinical trial of its kind, as much as a ... administering the formula prior to CT scans. "In ...
Cached Biology News:New cancer drug discovered at U-M heads to clinical trials 2Fibroids cause women's lower urinary tract problems: uterine fibroid embolization helps 2Fibroids cause women's lower urinary tract problems: uterine fibroid embolization helps 3Antioxidant formula prior to radiation exposure may prevent DNA injury 2
Recombinant Human CCL21/6Ckine (Mucin Stalk Chimera)...
One-step, microplate or cuvet, colorimetric, detection range 0.78 ug/dL to 65 ug/dL Zn in serum, plasma, urine, saliva etc. Procedure: 10 min....
Zebrafish Ephrin-B2 Biotinylated Affinity Purified PAb...
... Customer Peptide Synthesis , Containing one Phospho-Amino Acid ... returned to customer conjugation of peptide to KLH protein , ... 102 days/each , Pre-immune bleed x1 /each ... Test bleed (app. 5 ml) x1 /each ...
Biology Products: